Report overview
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems. This report contains market size and forecasts of Injectable Drug Delivery Systems in global, including the following market information:
Global Injectable Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Injectable Drug Delivery Systems Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Injectable Drug Delivery Systems companies in 2022 (%)
The global Injectable Drug Delivery Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pre-filled Syringes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Drug Delivery Systems include Baxter, Becton, Dickinson, Gerresheimer, Pfizer, Schott, ELI Lilly, Novartis, Terumo and Teva Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Pre-filled Syringes
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Global Injectable Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Hospitals & Clinics
Home Care
Others
Global Injectable Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Drug Delivery Systems revenues share in global market, 2022 (%)
Key companies Injectable Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Injectable Drug Delivery Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Drug Delivery Systems, market overview.
Chapter 2: Global Injectable Drug Delivery Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Drug Delivery Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
